Ronald G. Wiegand

579 total citations
22 papers, 433 citations indexed

About

Ronald G. Wiegand is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Spectroscopy. According to data from OpenAlex, Ronald G. Wiegand has authored 22 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Spectroscopy. Recurrent topics in Ronald G. Wiegand's work include Analytical Chemistry and Chromatography (5 papers), Analytical Methods in Pharmaceuticals (4 papers) and Biochemical Analysis and Sensing Techniques (3 papers). Ronald G. Wiegand is often cited by papers focused on Analytical Chemistry and Chromatography (5 papers), Analytical Methods in Pharmaceuticals (4 papers) and Biochemical Analysis and Sensing Techniques (3 papers). Ronald G. Wiegand collaborates with scholars based in United Kingdom, United States and Italy. Ronald G. Wiegand's co-authors include J.D. Taylor, James C.‐H. Mao, Alexander Chun, Paul G. Sanders, G. M. Everett, F Rinaldi, Stanley M. Crain, R. K. Richards, Robert C. Sonders and Mary A. Fox and has published in prestigious journals such as Journal of the American Chemical Society, Analytical Chemistry and Annals of the New York Academy of Sciences.

In The Last Decade

Ronald G. Wiegand

22 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronald G. Wiegand United Kingdom 13 139 89 67 45 42 22 433
C. C. Porter United States 11 118 0.8× 87 1.0× 50 0.7× 45 1.0× 37 0.9× 25 472
E. G. Tomich Germany 15 229 1.6× 155 1.7× 79 1.2× 54 1.2× 33 0.8× 38 796
B. J. Ludwig United States 15 141 1.0× 75 0.8× 83 1.2× 118 2.6× 58 1.4× 50 585
W. Hespe United States 10 158 1.1× 203 2.3× 66 1.0× 22 0.5× 22 0.5× 30 438
C. M. Williams United States 13 146 1.1× 95 1.1× 74 1.1× 42 0.9× 87 2.1× 35 561
R Nickander United States 11 140 1.0× 111 1.2× 133 2.0× 54 1.2× 36 0.9× 18 467
Norio AWATA United States 12 152 1.1× 84 0.9× 63 0.9× 60 1.3× 65 1.5× 58 508
Paul J. A. Demoen Belgium 10 120 0.9× 44 0.5× 65 1.0× 181 4.0× 58 1.4× 24 593
A. von Hodenberg Germany 10 193 1.4× 98 1.1× 55 0.8× 84 1.9× 38 0.9× 17 636
A. F. Crowther United Kingdom 11 241 1.7× 74 0.8× 56 0.8× 136 3.0× 44 1.0× 16 784

Countries citing papers authored by Ronald G. Wiegand

Since Specialization
Citations

This map shows the geographic impact of Ronald G. Wiegand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald G. Wiegand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald G. Wiegand more than expected).

Fields of papers citing papers by Ronald G. Wiegand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald G. Wiegand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald G. Wiegand. The network helps show where Ronald G. Wiegand may publish in the future.

Co-authorship network of co-authors of Ronald G. Wiegand

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald G. Wiegand. A scholar is included among the top collaborators of Ronald G. Wiegand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald G. Wiegand. Ronald G. Wiegand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wiegand, Ronald G., et al.. (1998). An exponential expression for in vitro release of drug from sustained-release preparations.. PubMed. 27. 165–71. 2 indexed citations
2.
Sonders, Robert C., et al.. (1974). Cyclamate and cyclohexylamine: lack of effect on the chromosomes of man and rats in vivo. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 26(3). 199–203. 13 indexed citations
3.
Wiegand, Ronald G. & Alexander Chun. (1972). Serum Protein Binding of Erythromycincand Erythromycin 2'-Propionate Ester. Journal of Pharmaceutical Sciences. 61(3). 425–428. 35 indexed citations
4.
Mao, James C.‐H., et al.. (1970). Biochemical basis for the selective toxicity of erythromycin. Biochemical Pharmacology. 19(2). 391–399. 9 indexed citations
5.
Martin, Yvonne C. & Ronald G. Wiegand. (1970). Metabolism and Excretion of Chromonar and Its Metabolite in Dog and Man. Journal of Pharmaceutical Sciences. 59(9). 1313–1318. 1 indexed citations
6.
Taylor, J.D., et al.. (1968). Toxicological studies with sodium cyclamate and saccharin. Food and Cosmetics Toxicology. 6(3). 313–327. 32 indexed citations
7.
Mao, James C.‐H. & Ronald G. Wiegand. (1968). Mode of action of macrolides. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 157(2). 404–413. 41 indexed citations
8.
Sonders, Robert C., et al.. (1968). Excretion of Cyclamate in the Rat. Journal of AOAC INTERNATIONAL. 51(1). 136–140. 3 indexed citations
9.
Wiegand, Ronald G. & Paul G. Sanders. (1964). CALCULATION OF KINETIC CONSTANTS FROM BLOOD LEVELS OF DRUGS. Journal of Pharmacology and Experimental Therapeutics. 146(3). 271–275. 27 indexed citations
10.
Wiegand, Ronald G., et al.. (1963). RELATION BETWEEN NOREPINEPHRINE ACCUMULATION OR DEPLETION AND BLOOD PRESSURE RESPONSES IN THE CAT AND RAT FOLLOWING PARGYLINE ADMINISTRATION. Annals of the New York Academy of Sciences. 107(3). 924–934. 17 indexed citations
11.
Wiegand, Ronald G., et al.. (1963). Multiple Dose Excretion Kinetics. Journal of Pharmaceutical Sciences. 52(3). 268–273. 19 indexed citations
12.
Everett, G. M., Ronald G. Wiegand, & F Rinaldi. (1963). PHARMACOLOGIC STUDIES OF SOME NONHYDRAZINE MAO INHIBITORS. Annals of the New York Academy of Sciences. 107(3). 1068–1080. 32 indexed citations
13.
Taylor, J.D. & Ronald G. Wiegand. (1962). The analog computer and plasma drug kinetics. Clinical Pharmacology & Therapeutics. 3(4). 464–472. 20 indexed citations
14.
Wiegand, Ronald G., et al.. (1962). DETERMINATION OF 5‐HYDROXYTRYPTOPHAN AND SEROTONIN. Journal of Neurochemistry. 9(2). 113–114. 10 indexed citations
15.
Everett, G. M. & Ronald G. Wiegand. (1961). 540 Non-hydrazide monoamine oxidase inhibitors and their effects on central amines and motor behaviour. Biochemical Pharmacology. 8(1). 163–163. 5 indexed citations
16.
Crain, Stanley M. & Ronald G. Wiegand. (1961). Catecholamine Levels of Mouse Sympathetic Ganglia Following Hypertrophy Produced by Salivary Nerve-Growth Factor. Experimental Biology and Medicine. 107(3). 663–665. 18 indexed citations
17.
Wiegand, Ronald G. & J.D. Taylor. (1960). Kinetics of plasma drug levels after sustained release dosage. Biochemical Pharmacology. 3(4). 256–263. 27 indexed citations
18.
Wiegand, Ronald G., et al.. (1960). XANTHURENIC ACID EXCRETION AND POSSIBLE PYRIDOXINE DEFICIENCY PRODUCED BY ISONICOTINIC ACID HYDRAZIDE AND OTHER CONVULSANT HYDRAZIDES. Journal of Pharmacology and Experimental Therapeutics. 128(4). 344–348. 12 indexed citations
19.
Wiegand, Ronald G.. (1959). Equilibrium Dialysis Vessel for Analysis of Drug-Macromolecule Interactions. Analytical Chemistry. 31(10). 1745–1746. 3 indexed citations
20.
Wiegand, Ronald G.. (1956). The Formation of Pyridoxal and Pyridoxal 5-Phosphate Hydrazones1. Journal of the American Chemical Society. 78(20). 5307–5309. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. C. Porter Breakdown of academic impact, for papers by E. G. Tomich Breakdown of academic impact, for papers by B. J. Ludwig Breakdown of academic impact, for papers by W. Hespe Breakdown of academic impact, for papers by C. M. Williams Breakdown of academic impact, for papers by R Nickander Breakdown of academic impact, for papers by Norio AWATA Breakdown of academic impact, for papers by Paul J. A. Demoen Breakdown of academic impact, for papers by A. von Hodenberg Breakdown of academic impact, for papers by A. F. Crowther
Rankless by CCL
2026